Hereditary neoplastic syndrome

Part of

Sub-types of Hereditary neoplastic syndrome

• Glioma susceptibility 0 trials · 133 incl. sub-types
  10 sub-types

  • Glioma susceptibility 1 133 trials
  • Glioma susceptibility 2 0 trials
  • Glioma susceptibility 3 0 trials
  • Glioma susceptibility 4 0 trials
  • Glioma susceptibility 5 0 trials
  • Glioma susceptibility 6 0 trials
  • Glioma susceptibility 7 0 trials
  • Glioma susceptibility 8 0 trials
  • Melanoma, cutaneous malignant, susceptibility to, 9 0 trials
  • Tumor predisposition syndrome 3 0 trials
• Neurofibromatosis 19 trials · 94 incl. sub-types
  5 sub-types

  • Neurofibromatosis type 1 73 trials Sub-types →
  • NF2-related schwannomatosis 21 trials
  • Schwannomatosis 3 trials Sub-types →
  • Neurofibromatosis-Noonan syndrome 2 trials Sub-types →
  • Neurofibromatosis, type IV, of Riccardi 0 trials
• Hereditary nonpolyposis colon cancer 5 trials · 88 incl. sub-types
  5 sub-types

  • Lynch syndrome 81 trials · 83 incl. sub-types Sub-types →
  • Muir-Torre syndrome 2 trials
  • Colorectal cancer, hereditary nonpolyposis, type 6 1 trial
  • Colorectal cancer, hereditary nonpolyposis, type 7 0 trials
  • Familial colorectal cancer type X 0 trials
• Multiple endocrine neoplasia 7 trials · 62 incl. sub-types
  3 sub-types

  • Multiple endocrine neoplasia type 1 34 trials
  • Multiple endocrine neoplasia type 2 4 trials · 30 incl. sub-types Sub-types →
  • Multiple endocrine neoplasia type 4 0 trials
• Intestinal polyposis syndrome 3 trials · 53 incl. sub-types
  8 sub-types

  • Classic or attenuated familial adenomatous polyposis 0 trials · 35 incl. sub-types Sub-types →
  • Peutz-Jeghers syndrome 9 trials
  • Hereditary mixed polyposis syndrome 5 trials · 6 incl. sub-types Sub-types →
  • Juvenile polyposis syndrome 5 trials Sub-types →
  • Bannayan-Riley-Ruvalcaba syndrome 1 trial
  • Cronkhite-Canada syndrome 1 trial
  • Hyperplastic polyposis syndrome 1 trial Sub-types →
  • Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome 0 trials
• Tuberous sclerosis 41 trials · 44 incl. sub-types
  2 sub-types

  • Tuberous sclerosis 1 33 trials
  • Tuberous sclerosis 2 2 trials
• Leukemia, acute lymphocytic, susceptibility to, 1 41 trials
• BRCA2-related cancer predisposition 36 trials · 38 incl. sub-types
  3 sub-types

  • Breast-ovarian cancer, familial, susceptibility to, 2 2 trials
  • Glioma susceptibility 3 0 trials
  • Pancreatic cancer, susceptibility to, 2 0 trials
• Hereditary breast ovarian cancer syndrome 35 trials · 38 incl. sub-types
  2 sub-types

  • Breast-ovarian cancer, familial, susceptibility to, 1 3 trials
  • Breast-ovarian cancer, familial, susceptibility to, 2 2 trials
• Mismatch repair cancer syndrome 1 34 trials
• BRCA1-related cancer predisposition 23 trials · 27 incl. sub-types
  2 sub-types

  • Breast-ovarian cancer, familial, susceptibility to, 1 3 trials
  • Pancreatic cancer, susceptibility to, 4 1 trial
• Nasopharyngeal carcinoma, susceptibility to, 1 21 trials
• Li-Fraumeni syndrome 16 trials
• PALB2-related cancer predisposition 14 trials
  1 sub-type

  • Pancreatic cancer, susceptibility to, 3 0 trials
• Dyskeratosis congenita 12 trials
  16 sub-types

  • DKC1-related disorder 0 trials · 3 incl. sub-types Sub-types →
  • Revesz syndrome 2 trials
  • Dyskeratosis congenita and related telomere biology disorder 1 trial Sub-types →
  • Autosomal recessive dyskeratosis congenita 4 0 trials
  • Dyskeratosis congenita, autosomal dominant 1 0 trials
  • Dyskeratosis congenita, autosomal dominant 2 0 trials
  • Dyskeratosis congenita, autosomal dominant 3 0 trials
  • Dyskeratosis congenita, autosomal dominant 4 0 trials
  • Dyskeratosis congenita, autosomal dominant 6 0 trials
  • Dyskeratosis congenita, autosomal recessive 1 0 trials
  • Dyskeratosis congenita, autosomal recessive 2 0 trials
  • Dyskeratosis congenita, autosomal recessive 3 0 trials
  • Dyskeratosis congenita, autosomal recessive 6 0 trials
  • Dyskeratosis congenita, autosomal recessive 7 0 trials
  • Dyskeratosis congenita, autosomal recessive 8 0 trials
  • Dyskeratosis congenita, digenic 0 trials
• Wiskott-Aldrich syndrome 10 trials
• Hereditary leiomyomatosis and renal cell cancer 8 trials
• PTEN hamartoma tumor syndrome 6 trials · 8 incl. sub-types
  4 sub-types

  • Proteus syndrome 2 trials
  • Bannayan-Riley-Ruvalcaba syndrome 1 trial
  • Proteus-like syndrome 0 trials
  • Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome 0 trials
• CHEK2-related cancer predisposition 7 trials
• Susceptibility to familial cutaneous melanoma 0 trials · 7 incl. sub-types
  10 sub-types

  • Melanoma, cutaneous malignant, susceptibility to, 2 6 trials
  • Melanoma, cutaneous malignant, susceptibility to, 1 1 trial
  • Melanoma, cutaneous malignant, susceptibility to, 3 0 trials
  • Melanoma, cutaneous malignant, susceptibility to, 4 0 trials
  • Melanoma, cutaneous malignant, susceptibility to, 5 0 trials
  • Melanoma, cutaneous malignant, susceptibility to, 6 0 trials
  • Melanoma, cutaneous malignant, susceptibility to, 7 0 trials
  • Melanoma, cutaneous malignant, susceptibility to, 8 0 trials
  • Melanoma, cutaneous malignant, susceptibility to, 9 0 trials
  • Tumor predisposition syndrome 3 0 trials
• BAP1-related tumor predisposition syndrome 6 trials
• Beckwith-Wiedemann syndrome 6 trials
  8 sub-types

  • Beckwith-Wiedemann syndrome due to 11p15 microdeletion 0 trials
  • Beckwith-Wiedemann syndrome due to 11p15 microduplication 0 trials
  • Beckwith-Wiedemann syndrome due to 11p15 translocation/inversion 0 trials
  • Beckwith-Wiedemann syndrome due to CDKN1C mutation 0 trials
  • Beckwith-Wiedemann syndrome due to NSD1 mutation 0 trials
  • Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 0 trials
  • Beckwith-Wiedemann syndrome due to paternal uniparental disomy of chromosome 11 0 trials
  • Franceschini Vardeu Guala syndrome 0 trials
• RAD51C-related cancer predisposition 6 trials
• Hereditary pheochromocytoma-paraganglioma 6 trials
  9 sub-types

  • MAX-related tumor predisposition 0 trials
  • TMEM127-related tumor predisposition 0 trials
  • Pheochromocytoma/paraganglioma syndrome 1 0 trials
  • Pheochromocytoma/paraganglioma syndrome 2 0 trials
  • Pheochromocytoma/paraganglioma syndrome 3 0 trials
  • Pheochromocytoma/paraganglioma syndrome 4 0 trials
  • Pheochromocytoma/paraganglioma syndrome 5 0 trials
  • Pheochromocytoma/paraganglioma syndrome 6 0 trials
  • Pheochromocytoma/paraganglioma syndrome 7 0 trials
• Nevoid basal cell carcinoma syndrome 5 trials
  2 sub-types

  • Basal cell nevus syndrome 1 0 trials
  • Basal cell nevus syndrome 2 0 trials
• Hereditary thrombocytopenia and hematologic cancer predisposition syndrome 1 trial · 5 incl. sub-types
  2 sub-types

  • Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 5 trials
  • Thrombocytopenia 5 0 trials
• RAD51D-related cancer predisposition 4 trials
• Kostmann syndrome 3 trials
• Li-fraumeni-like syndrome 3 trials
• Familial atypical multiple mole melanoma syndrome 3 trials
  1 sub-type

  • Melanoma-pancreatic cancer syndrome 0 trials
• Hereditary multiple osteochondromas 3 trials
  3 sub-types

  • Exostoses, multiple, type 1 2 trials
  • Exostoses, multiple, type 2 0 trials
  • Exostoses, multiple, type III 0 trials
• BARD1-related cancer predisposition 2 trials
• Maffucci syndrome 2 trials
• Blue rubber bleb nevus 2 trials
• Hereditary retinoblastoma 2 trials
• Inherited hematologic cancer-predisposing syndrome 2 trials
• Leukemia, chronic lymphocytic, susceptibility to, 2 2 trials
• Neuroblastoma, susceptibility to, 3 2 trials
• Brooke-Spiegler syndrome 0 trials · 2 incl. sub-types
  2 sub-types

  • Familial cylindromatosis 2 trials
  • Familial multiple trichoepithelioma 0 trials Sub-types →
• Rothmund-Thomson syndrome 1 trial
  4 sub-types

  • Rothmund-Thomson syndrome type 1 0 trials
  • Rothmund-Thomson syndrome type 2 0 trials
  • Rothmund-Thomson syndrome type 3 0 trials
  • Rothmund-Thomson syndrome type 4 0 trials
• SAMD9-related spectrum and myeloid neoplasm risk 1 trial
• SAMD9L-related spectrum and myeloid neoplasm risk 1 trial
• WAGR syndrome 1 trial
  1 sub-type

  • Wilms tumor, aniridia, genitourinary anomalies, intellectual disability, and obesity syndrome 0 trials
• Cherubism 1 trial
  1 sub-type

  • Al Gazali Khidr Prem Chandran syndrome 0 trials
• Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors 1 trial
• Hyperparathyroidism 2 with jaw tumors 1 trial
• Familial rhabdoid tumor 0 trials · 1 incl. sub-types
  2 sub-types

  • Rhabdoid tumor predisposition syndrome 2 1 trial
  • Rhabdoid tumor predisposition syndrome 1 0 trials
• ATM-related cancer predisposition 0 trials
• CDH1-related diffuse gastric and lobular breast cancer syndrome 0 trials
• Carney-Stratakis syndrome 0 trials
• Cobb syndrome 0 trials
• DDX41-related hematologic malignancy predisposition syndrome 0 trials
• EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition 0 trials
• GPR161-related medulloblastoma predisposition 0 trials
• HAVCR2-related cancer predisposition 0 trials
• Kaposi sarcoma, susceptibility to 0 trials
• N syndrome 0 trials
• NTHL1-deficiency tumor predisposition syndrome 0 trials
• Basal cell carcinoma, susceptibility to, 7 0 trials
• Breast cancer, familial, susceptibility to, 1 0 trials
• Breast cancer, familial, susceptibility to, 2 0 trials
• Breast cancer, familial, susceptibility to, 3 0 trials
• Cholangiocarcinoma, susceptibility to 0 trials
• Colorectal cancer, susceptibility to, 1 0 trials
• Colorectal cancer, susceptibility to, 10 0 trials
• Colorectal cancer, susceptibility to, 11 0 trials
• Colorectal cancer, susceptibility to, 12 0 trials
• Colorectal cancer, susceptibility to, 2 0 trials
• Colorectal cancer, susceptibility to, 3 0 trials
• Colorectal cancer, susceptibility to, 4 0 trials
• Colorectal cancer, susceptibility to, 5 0 trials
• Colorectal cancer, susceptibility to, 6 0 trials
• Colorectal cancer, susceptibility to, 7 0 trials
• Colorectal cancer, susceptibility to, 8 0 trials
• Colorectal cancer, susceptibility to, 9 0 trials
• Colorectal cancer, susceptibility to, on chromosome 15 0 trials
• Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate 0 trials
• Erythroleukemia, familial, susceptibility to 0 trials
• Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome 0 trials
• Familial isolated hyperparathyroidism 0 trials
  3 sub-types

  • Hyperparathyroidism 1 0 trials
  • Hyperparathyroidism 3 0 trials
  • Hyperparathyroidism 4 0 trials
• Familial multiple fibrofolliculoma 0 trials
• Follicular lymphoma, susceptibility to 0 trials
  2 sub-types

  • Follicular lymphoma, susceptibility to, 1 0 trials
  • Follicular lymphoma, susceptibility to, 2 0 trials
• Hemangioma, capillary infantile, susceptibility to 0 trials
• Leukemia, acute lymphoblastic, susceptibility to, 3 0 trials
• Leukemia, acute lymphocytic, susceptibility to, 2 0 trials
• Leukemia, acute myeloid, susceptibility to 0 trials
• Leukemia, chronic lymphocytic, susceptibility to, 1 0 trials
• Leukemia, chronic lymphocytic, susceptibility to, 3 0 trials
• Leukemia, chronic lymphocytic, susceptibility to, 4 0 trials
• Leukemia, chronic lymphocytic, susceptibility to, 5 0 trials
• Lung cancer susceptibility 1 0 trials
• Lung cancer susceptibility 3 0 trials
• Lung cancer susceptibility 4 0 trials
• Lung cancer susceptibility 5 0 trials
• Melanoma and neural system tumor syndrome 0 trials
• Mosaic neurofibromatosis/schwannomatosis 0 trials
  3 sub-types

  • Mosaic NF2-related schwannomatosis 0 trials
  • Mosaic neurofibromatosis type 1 0 trials
  • Mosaic schwannomatosis 0 trials
• Mosaic variegated aneuploidy syndrome 0 trials
  7 sub-types

  • Atelis syndrome 1 0 trials
  • Atelis syndrome 2 0 trials
  • Mosaic variegated aneuploidy syndrome 1 0 trials
  • Mosaic variegated aneuploidy syndrome 2 0 trials
  • Mosaic variegated aneuploidy syndrome 3 0 trials
  • Mosaic variegated aneuploidy syndrome 4 0 trials
  • Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition 0 trials
• Multiple self-healing squamous epithelioma 0 trials
• Nasopharyngeal carcinoma, susceptibility to, 2 0 trials
• Nasopharyngeal carcinoma, susceptibility to, 3 0 trials
• Neuroblastoma, susceptibility to, 1 0 trials
• Neuroblastoma, susceptibility to, 2 0 trials
• Neuroblastoma, susceptibility to, 4 0 trials
• Neuroblastoma, susceptibility to, 5 0 trials
• Neuroblastoma, susceptibility to, 6 0 trials
• Neuroblastoma, susceptibility to, 7 0 trials
• Ovarian cancer, familial, susceptibility to, 1 0 trials
• Ovarian cancer, familial, susceptibility to, 2 0 trials
• Ovarian cancer, familial, susceptibility to, 3 0 trials
• Ovarian cancer, susceptibility to, 1 0 trials
• Pancreatic cancer, susceptibility to, 1 0 trials
• Pancreatic cancer, susceptibility to, 5 0 trials
• Progeroid features-hepatocellular carcinoma predisposition syndrome 0 trials
• Prostate cancer, hereditary, X-linked 3 0 trials
• Prostate cancer/brain cancer susceptibility 0 trials
• Susceptibility to uveal melanoma 0 trials
  2 sub-types

  • Melanoma, uveal, susceptibility to, 1 0 trials
  • Melanoma, uveal, susceptibility to, 2 0 trials
• Tumor predisposition syndrome 2 0 trials